TrialJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2019

Lumacaftor/Ivacaftor reduces pulmonary exacerbations in patients irrespective of initial changes in FEV

Susanna A McColley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.